Some eligible Amazon customers have just 30 days left to file a claim in the company's $2.5 billion settlement with the Federal Trade Commission. While not all Amazon customers are eligible, those who ...

GLP-1 receptor agonists (GLP-1 RAs) are associated with reduced incidence of breast cancer among women with overweight or obesity, according to two observational studies. One found that GLP-1 RA users ...

The Federal Trade Commission has finalized an order requiring Rollins Inc., the pest-control giant behind Orkin, HomeTeam Pest Defense, and Critter Control, to stop enforcing noncompete agreements ...

A new lawsuit filed by the U.S. Federal Trade Commission (FTC) is a showcase of how hard it’s become to police the app stores for scammy apps. The suit alleges that a company known as Genesis Tech ...

Homicide detectives are investigating a triple shooting that occurred early Saturday morning in the Federal Hill neighborhood, according to Baltimore police.Officials say units responded to the 1000 ...

Off-label use of medications like Ozempic, Wegovy, Mounjaro, and Zepbound is becoming increasingly common to address weight management, insulin resistance, and diabetes related complications in type 1 ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two dozen ...

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not ...

Dr McDonald shares promising data linking GLP-1 use to lower breast cancer risk, highlighting the need for clinical trials to prove prevention. A recent large-scale study presented at the 2026 ASCO ...

OPM requires FEHB plans to cover at least one GLP-1 prescribed for weight loss, and this extends to any Part D or Medicare Advantage plan offered by an FEHB carrier. As a result, most annuitants with ...